We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
On completion of the aforesaid investment, Advanced Enzyme Technologies will get a controlling stake of 51 per cent in SciTech Specialties with a total shareholding of 520,408 equity shares.